Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Acta Neuropathologica|October 6, 2016
Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitisClaudia Cantoni, Francesca Cignarella, Laura Ghezzi, et al.
Annals of Neurology|October 3, 2025
From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple SclerosisLaura Ghezzi, Peter Kosa, Mark Greenwood, et al.
Cell Metabolism|June 7, 2018
Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut MicrobiotaFrancesca Cignarella, Claudia Cantoni, Laura Ghezzi, et al.
Immunotherapy|December 18, 2013
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathyAlberto Calvi, Milena De Riz, Anna M Pietroboni, et al.
Multiple Sclerosis and Related Disorders|November 1, 2019
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosisAnna M Pietroboni, Francesca Schiano di Cola, Annalisa Colombi, et al.
Journal of Alzheimer'S Disease : JAD|December 16, 2020
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic SyndromeTiziana Carandini, Luca Sacchi, Laura Ghezzi, et al.
Neurology|November 2, 2012
A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutationLaura Ghezzi, Elio Scarpini, Mario Rango, et al.
Journal of Alzheimer'S Disease : JAD|May 11, 2012
Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentationsAndrea Arighi, Giorgio G Fumagalli, Francesca Jacini, et al.
Multiple Sclerosis and Related Disorders|December 30, 2019
Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosisAnna M Pietroboni, Annalisa Colombi, Tiziana Carandini, et al.
Alzheimer'S Research & Therapy|October 17, 2019
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromesTiziana Carandini, Andrea Arighi, Luca Sacchi, et al.
Pageof 7